HeartBeam (BEAT)
(Delayed Data from NSDQ)
$2.36 USD
-0.05 (-2.07%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $2.35 -0.01 (-0.42%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BEAT 2.36 -0.05(-2.07%)
Will BEAT be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for BEAT based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for BEAT
HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript
HeartBeam, Inc. Advances Cardiac Monitoring Solutions
HeartBeam GAAP EPS of -$0.19
HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...
HeartBeam reports Q3 EPS (19c), two estimates (17c)